Synopsys, Inc. $SNPS Shares Bought by Wendell David Associates Inc.

Wendell David Associates Inc. raised its position in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 78.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,638 shares of the semiconductor company’s stock after buying an additional 1,156 shares during the period. Wendell David Associates Inc.’s holdings in Synopsys were worth $1,302,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Alpine Bank Wealth Management lifted its position in shares of Synopsys by 89.3% during the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares during the last quarter. TFC Financial Management Inc. raised its position in shares of Synopsys by 1,250.0% during the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after acquiring an additional 50 shares in the last quarter. Millstone Evans Group LLC acquired a new stake in shares of Synopsys during the 3rd quarter valued at approximately $27,000. Independence Bank of Kentucky lifted its stake in Synopsys by 120.0% during the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 30 shares during the last quarter. Finally, SOA Wealth Advisors LLC. acquired a new position in Synopsys in the third quarter worth $28,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Synopsys

In other news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Janet Lee sold 250 shares of the company’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 4,157 shares of company stock worth $1,945,036. 0.62% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on SNPS shares. Wells Fargo & Company raised their price target on shares of Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 11th. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. BNP Paribas Exane began coverage on Synopsys in a research note on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 target price for the company. KeyCorp increased their price target on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Finally, Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and reduced their price objective for the company from $605.00 to $560.00 in a research report on Tuesday, December 9th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $553.57.

View Our Latest Research Report on SNPS

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $509.47 on Friday. The stock has a market cap of $97.47 billion, a P/E ratio of 63.76, a P/E/G ratio of 4.35 and a beta of 1.12. The firm’s 50-day simple moving average is $464.74 and its 200 day simple moving average is $504.52. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys’s quarterly revenue was up 37.8% on a year-over-year basis. During the same quarter last year, the company earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Equities analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.